ImageneBio, Inc. (IMA)
NASDAQ · Healthcare
ImageneBio, Inc. Shareholder Equity 2020–2025
ImageneBio, Inc. annual/quarterly shareholder equity history from 2020 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- ImageneBio, Inc. shareholder equity for the quarter ending December 31, 2025 were 133.1M, a 182.92% decrease year-over-year.
- ImageneBio, Inc. shareholder equity for 2025 were 133.1M, a 182.92% decrease from 2024.
- ImageneBio, Inc. shareholder equity for 2024 were -160.6M, a 27.32% increase from 2023.
- ImageneBio, Inc. shareholder equity for 2023 were -126.1M, a 185.81% decrease from 2022.
- ImageneBio, Inc. shareholder equity for 2022 were 147.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| ImageneBio, Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $133 |
| 2024 | $-161 |
| 2023 | $-126 |
| 2022 | $147 |
| 2021 | $208 |
| 2020 | $-101 |
| ImageneBio, Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $133 |
| 2024-12-31 | $-161 |
| 2023-12-31 | $-126 |
| 2022-12-31 | $147 |
| 2021-12-31 | $208 |
| 2020-12-31 | $-101 |
ImageneBio, Inc. Shareholder Equity — FAQ
ImageneBio, Inc. (IMA) shareholder equity over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMA's shareholder equity history?
The chart and table above show ImageneBio, Inc.'s shareholder equity by year and by quarter, including the growth rate.